Loading...
dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 1304319000

Production
add
1304319000
The component that hold information about this concept.
Product containing precisely emtricitabine 200 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Product containing precisely emtricitabine 200 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)

SCTID: 1304319000, Defined, Active


1304319000|Product containing precisely emtricitabine 200 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)|
  • en Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
  • en Product containing precisely emtricitabine 200 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)

1304319000 |Product containing precisely emtricitabine 200 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)|

=== 421026006 |Conventional release oral tablet (dose form)| +
    732936001 |Tablet (unit of presentation)| +
    1304320006 |Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form)| :
        { 732943007 |Has basis of strength substance (attribute)| = 404856006 |Emtricitabine (substance)|,
          762949000 |Has precise active ingredient (attribute)| = 404856006 |Emtricitabine (substance)|,
          732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
          732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        { 732943007 |Has basis of strength substance (attribute)| = 421203005 |Tenofovir disoproxil (substance)|,
          762949000 |Has precise active ingredient (attribute)| = 385556006 |Tenofovir disoproxil fumarate (substance)|,
          732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
          732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        { 732943007 |Has basis of strength substance (attribute)| = 703123005 |Rilpivirine (substance)|,
          762949000 |Has precise active ingredient (attribute)| = 703124004 |Rilpivirine hydrochloride (substance)|,
          732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
          732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
Active

5310133012 - Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet (en) View

5310133012
en
Synonym (core metadata concept)
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

5310134018 - Product containing precisely emtricitabine 200 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) (en) View

5310134018
en
Fully specified name (core metadata concept)
Product containing precisely emtricitabine 200 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

Relationship (15909298020) - 1304319000 -> 788073005 (766939001) View

766939001 |Plays role (attribute)|
788073005 |Antiretroviral therapeutic role (role)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (15909295023) - 1304319000 -> 421026006 (411116001) View

411116001 |Has dose form (attribute)|
421026006 |Conventional release oral tablet (dose form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909296024) - 1304319000 -> 732936001 (763032000) View

763032000 |Has unit of presentation (attribute)|
732936001 |Tablet (unit of presentation)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909299028) - 1304319000 -> 404856006 (762949000) View

762949000 |Has precise active ingredient (attribute)|
404856006 |Emtricitabine (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909300020) - 1304319000 -> 404856006 (732943007) View

732943007 |Has basis of strength substance (attribute)|
404856006 |Emtricitabine (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909302028) - 1304319000 -> 258684004 (732945000) View

732945000 |Has presentation strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909304027) - 1304319000 -> 732936001 (732947008) View

732947008 |Has presentation strength denominator unit (attribute)|
732936001 |Tablet (unit of presentation)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909305026) - 1304319000 -> 385556006 (762949000) View

762949000 |Has precise active ingredient (attribute)|
385556006 |Tenofovir disoproxil fumarate (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909306025) - 1304319000 -> 421203005 (732943007) View

732943007 |Has basis of strength substance (attribute)|
421203005 |Tenofovir disoproxil (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909308029) - 1304319000 -> 258684004 (732945000) View

732945000 |Has presentation strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909310027) - 1304319000 -> 732936001 (732947008) View

732947008 |Has presentation strength denominator unit (attribute)|
732936001 |Tablet (unit of presentation)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909311028) - 1304319000 -> 703124004 (762949000) View

762949000 |Has precise active ingredient (attribute)|
703124004 |Rilpivirine hydrochloride (substance)|
3
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909312024) - 1304319000 -> 703123005 (732943007) View

732943007 |Has basis of strength substance (attribute)|
703123005 |Rilpivirine (substance)|
3
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909314020) - 1304319000 -> 258684004 (732945000) View

732945000 |Has presentation strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
3
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909316022) - 1304319000 -> 732936001 (732947008) View

732947008 |Has presentation strength denominator unit (attribute)|
732936001 |Tablet (unit of presentation)|
3
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15909321020) - 1304319000 -> 1304320006 (116680003) View

116680003 |Is a (attribute)|
1304320006 |Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

1304320006 View

1304320006
Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form)
Emtricitabine and rilpivirine and tenofovir only product in oral dose form
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

421026006 View

421026006
Conventional release oral tablet (dose form)
Oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

732936001 View

732936001
Tablet (unit of presentation)
Tablet
900000000000074008 |Necessary but not sufficient concept definition status (core metadata concept)|
True
esc